Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
(1) The primary objective is to use descriptive statistics to evaluate the safety of intravenous (IV) and/or oral 6- or 10-day tedizolid phosphate with 10- or 14-day IV and/or oral comparator in subjects 3 months to <12 years of age with acute bacterial skin and skin structure infections (ABSSSI). No formal hypothesis tests will be used to evaluate this endpoint.
Inclusion criteria
- acute bacterial skin and skin structure infections (abSSSI)